Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-12-16
pubmed:abstractText
Cruciferous vegetables contain significant amounts of ascorbigen and related substances with known molecular structures. This study tested the hypothesis that ascorbigen demonstrates antioxidant properties and protects human umbilical cord endothelial cells against hyperglycemic toxicity in vitro. It was observed that ascorbigen, in micromolar concentrations, protected against endothelial cell death from glucose toxicity. Additionally, ascorbigen at 3.0 mm shifted the concentration response curve of l-phenylephrine to the right, with a reduction in the maximal contractile effects of the agonist. This action was not related to alpha-adrenoceptor blockade. Ascorbigen also relaxed the vascular tone induced by l-phenylephrine, which is not mediated by an endothelial cell nitric oxide-dependent mechanism. On the guinea-pig ileum, the spasmogenic effects of carbachol, histamine and serotonin were reduced in the presence of 3 mM ascorbigen. Spasm of the gut induced by the acetylcholinesterase inhibitor, physostigmine, was antagonized by ascorbigen with an IC50 of 286 microM. This natural product also has a weak antiparasitic activity. The cytoprotective effects of ascorbigen may be highly relevant in the optimum physiological regulation of the function and the therapeutic value of this substance in disease settings needs to be further investigated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1099-1573
pubmed:author
pubmed:copyrightInfo
(c) 2008 John Wiley & Sons, Ltd.
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1581-6
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18844288-Animals, pubmed-meshheading:18844288-Antioxidants, pubmed-meshheading:18844288-Antiprotozoal Agents, pubmed-meshheading:18844288-Aorta, pubmed-meshheading:18844288-Ascorbic Acid, pubmed-meshheading:18844288-Biological Agents, pubmed-meshheading:18844288-Carbachol, pubmed-meshheading:18844288-Cell Survival, pubmed-meshheading:18844288-Cells, Cultured, pubmed-meshheading:18844288-Cytoprotection, pubmed-meshheading:18844288-Endothelial Cells, pubmed-meshheading:18844288-Glucose, pubmed-meshheading:18844288-Guinea Pigs, pubmed-meshheading:18844288-Histamine, pubmed-meshheading:18844288-Humans, pubmed-meshheading:18844288-Ileum, pubmed-meshheading:18844288-Indoles, pubmed-meshheading:18844288-Leishmania donovani, pubmed-meshheading:18844288-Muscle, Skeletal, pubmed-meshheading:18844288-Muscle Contraction, pubmed-meshheading:18844288-Phenylephrine, pubmed-meshheading:18844288-Physostigmine, pubmed-meshheading:18844288-Rana catesbeiana, pubmed-meshheading:18844288-Rats, pubmed-meshheading:18844288-Serotonin, pubmed-meshheading:18844288-Trachea
pubmed:year
2008
pubmed:articleTitle
Pharmacological and biological screening of ascorbigen: protection against glucose-induced endothelial cell toxicity.
pubmed:affiliation
Division of Pharmacology, College of Pharmacy, Columbus, OH 43210, USA.
pubmed:publicationType
Journal Article